000 01233 a2200361 4500
005 20250518030639.0
264 0 _c20200212
008 202002s 0 0 eng d
022 _a1876-4479
024 7 _a10.1093/ecco-jcc/jjz038
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSands, Bruce E
245 0 0 _aThe Impact of Raising the Bar for Clinical Trials in Ulcerative Colitis.
_h[electronic resource]
260 _bJournal of Crohn's & colitis
_cSep 2019
300 _a1217-1226 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aColitis, Ulcerative
_xdrug therapy
650 0 4 _aGastrointestinal Agents
_xtherapeutic use
650 0 4 _aHumans
650 0 4 _aRandomized Controlled Trials as Topic
_xmethods
650 0 4 _aRemission Induction
650 0 4 _aTreatment Outcome
700 1 _aCheifetz, Adam S
700 1 _aNduaka, Chudy I
700 1 _aQuirk, Daniel
700 1 _aWang, Wenjin
700 1 _aMaller, Eric
700 1 _aFriedman, Gary S
700 1 _aSu, Chinyu
700 1 _aHiggins, Peter D R
773 0 _tJournal of Crohn's & colitis
_gvol. 13
_gno. 9
_gp. 1217-1226
856 4 0 _uhttps://doi.org/10.1093/ecco-jcc/jjz038
_zAvailable from publisher's website
999 _c29484924
_d29484924